Remove 2023 Remove Compounding Remove Insurance Coverage
article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

These closures, compounded by the decline of independent pharmacies, create a critical gap in care. True visibility comes from layering pharmacy locations on top of geospatial data, such as population density, income levels, transportation access, insurance coverage, and health burden.

article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

Authors of a Journal of the American Medical Association study found that adolescent use of GLP-1s “increased substantially” between 2020 and 2023. February 9, 2023. Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 2020-2023. How obesity can affect your child now—and later in life.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

Compounding this issue, many pharmacies face ongoing staffing shortages, which hinder efficient operations and compromise the ability to deliver quality patient care. Overexpansion and staffing issues also play a role. This can expand access to underserved communities and improve patient outcomes.

article thumbnail

The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices

Pharmacy Times

The most common concerns include the following 1,3-5 : • Cost and insurance barriers: Affordability remains a major barrier, as patients have difficulty accessing CGMs due to high out-of-pocket costs or limited insurance coverage.

article thumbnail

A Review of Oral Cephalosporins for Common Outpatient Infections

Pharmacy Times

In 2023, 38.9 Additional considerations for selection between oral cephalosporin agents include differences in bioavailability and absorption, specific site of infection and the ability of drug to concentrate at that site, local resistance patterns, insurance coverage, available formulations, and cost to the patient.

article thumbnail

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

4 Though the US still stops short of requiring testing outright, this marks a critical turning point—shifting responsibility onto clinicians and paving the way for broader insurance coverage and adoption. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress.

article thumbnail

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

Pharmacy Times

Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurance coverage.